Filing Details

Accession Number:
0001179110-20-006457
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-21 19:13:02
Reporting Period:
2020-05-19
Accepted Time:
2020-05-21 19:13:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
720154 Bioanalytical Systems Inc BASI Services-Commercial Physical & Biological Research (8731) 351345024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522046 Beth Taylor C/O Bioanalytical Systems, Inc.
2701 Kent Avenue
West Lafayette IN 47906-1382
Vp- Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2020-05-19 5,067 $4.38 5,067 No 4 P Direct
Common Shares Acquisiton 2020-05-20 4,933 $4.42 10,000 No 4 P Direct
Common Shares Acquisiton 2020-05-21 3,300 $4.52 13,300 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The prices reported in column 4 are weighted average prices. These shares were purchased in multiple transactions at prices ranging from $4.26 to $4.39, inclusive with respect to the shares purchased on May 19, 2020, $4.22 to $4.81, inclusive with respect to the shares purchased on May 20, 2020, and $4.39 to $4.74, inclusive with respect to the shares purchased on May 21, 2020. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.